Company
Omeicos Therapeutics
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Omeicos is developing novel small molecule drugs for the treatment and prevention of atrial fibrillation using a first-in-class novel metabolite of omega 3 fatty acids.
Loading relationship preview